In summary, the literature reviewed herein has unequivocally shown neuroprotective effects of the exogenously induced Nrf2 activation in experimental models of ischemic stroke, providing a positive panorama and indicating that Nrf2 modulators may represent promising pharmacological strategies to treat ischemic stroke patients in a near future. Here, NFE2L2 is linked to ischemic stroke.